Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.
- NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_assertion description "[They had received VP16, methotrexate, 6MP/6TG, L-asparaginase, daunorubicin, cytarabine, and VM26 more often, likely attributed to the high frequency of AL as their primary disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.
- NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_assertion evidence source_evidence_literature NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.
- NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_assertion SIO_000772 11921271 NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.
- NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_assertion wasDerivedFrom befree-20150227 NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.
- NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_assertion wasGeneratedBy ECO_0000203 NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP948033.RAmTv6pS9Kl9qc6taJkrHv1YZbxDPmgKuwxRmB0hoRAc8130_provenance.